SCHEMBL24210010

SCHEMBL24210010

Cn1c2ccccc2c2cc(N3c4ccccc4C(C)(C)c4ccccc43)ccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.46
▸ MAPT P10636 4/20 0.44
▸ KDM4E B2RXH2 5/20 0.44
▸ ALDH1A1 P00352 3/20 0.44
▸ HPGD P15428 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ HSD17B10 Q99714 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ BCHE P06276 4/20 0.38
▸ ACHE P22303 4/20 0.38
▸ PABPC1 P11940 1/20 0.38
▸ KIF11 P52732 1/20 0.37
▸ NPY5R Q15761 1/20 0.36
▸ PSEN1 P49768 1/20 0.36
▸ PSEN2 P49810 1/20 0.36
▸ APH1B Q8WW43 1/20 0.36
▸ NCSTN Q92542 1/20 0.36
▸ APH1A Q96BI3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12117308 0.93 MAPT (0.36) GPR3MAPTKDM4EALDH1A1HPGD
SCHEMBL13143076 0.90 BCHE (0.46) GPR3MAPTKDM4EALDH1A1HPGD
SCHEMBL19269142 0.89 RXRA (0.41) GPR3MAPTKDM4EALDH1A1HPGD
SCHEMBL13365990 0.86 KDM4E (0.49) MAPTKDM4EALDH1A1HPGDKMT2A
SCHEMBL30010276 0.86 KDM4E (0.49) MAPTKDM4EALDH1A1HPGDKMT2A
SCHEMBL12116385 0.86 GPR3 (0.38) GPR3MAPTKDM4EALDH1A1HPGD
SCHEMBL17915763 0.85 KDM4E (0.37) MAPTKDM4EALDH1A1HPGDKMT2A
SCHEMBL12521346 0.85 MAPT (0.33) MAPTKDM4EALDH1A1HPGDKMT2A
SCHEMBL12117231 0.84 BCHE (0.32) MAPTKDM4EALDH1A1HPGDKMT2A
SCHEMBL12117259 0.84 PGR (0.33) MAPTKDM4EALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024151172-A1 CYANODIPHENYL SULFONE DERIVATIVES, A PROCESS FOR THEIR PREPARATION, AN EMISSIVE LAYER CONTAINING THEM, AN ELECTROLUMINESCENT DEVICE, AND THEIR USE Noctiluca S.A. (PL) 2024-07-18 — — WO disclosed
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-01-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220020937-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC1, ODC1, DDT GPR3 3645/4885MAPT 2418/4885KDM4E 1600/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback